AET - Aetna Inc.

NYSE - NYSE Delayed Price. Currency in USD
200.19
-1.30 (-0.65%)
At close: 4:01PM EDT

200.19 0.00 (0.00%)
After hours: 5:01PM EDT

Stock chart is not supported by your current browser
Previous Close201.49
Open201.39
Bid200.24 x 800
Ask200.99 x 800
Day's Range200.17 - 202.47
52 Week Range157.96 - 206.66
Volume2,063,881
Avg. Volume2,009,386
Market Cap65.542B
Beta (3Y Monthly)0.90
PE Ratio (TTM)18.87
EPS (TTM)10.61
Earnings DateOct 30, 2018
Forward Dividend & Yield2.00 (0.99%)
Ex-Dividend Date2018-10-23
1y Target Est205.93
Trade prices are not sourced from all markets
  • DOJ approves CVS, Aetna; Broadcom drops; Costco streaming; Starbucks offers new perk; Microsoft sinks
    Yahoo Finance Video9 days ago

    DOJ approves CVS, Aetna; Broadcom drops; Costco streaming; Starbucks offers new perk; Microsoft sinks

    Yahoo Finance’s Seana Smith on the stocks making headlines in midday trading Wednesday.

  • NY regulators consider blocking parts of CVS, Aetna deal
    American City Business Journals5 hours ago

    NY regulators consider blocking parts of CVS, Aetna deal

    New York state officials aren't happy with certain aspects of the $68 billion merger of drugstore store chain CVS Health Corp. and Aetna Inc. At a public hearing in Manhattan on Thursday, Maria Vullo — the superintendent of the state Department of Financial Services — said the deal could be blocked, and she called U.S. approval of the overall deal “myopic.” A major point of contention is that CVS and Aetna representatives have not provided written evidence that they would deliver on promises to lower the cost of prescription prices. Several groups, including the Pharmacists Society of the State of New York and the Medical Society of the State of New York, expect the merger will limit competition and make drugs more expensive. CVS and Aetna announced the deal in December 2017.

  • GlobeNewswire12 hours ago

    Analysis: Positioning to Benefit within Penumbra, Aetna, Littelfuse, IHS Markit, Credit Acceptance, and Insulet — Research Highlights Growth, Revenue, and Consolidated Results

    NEW YORK, Oct. 19, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Can Aetna (AET) Keep the Earnings Surprise Streak Alive?
    Zacksyesterday

    Can Aetna (AET) Keep the Earnings Surprise Streak Alive?

    Aetna (AET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • Is student loan assistance the next 401k?
    American City Business Journals2 days ago

    Is student loan assistance the next 401k?

    For a growing number of companies, offering employees student loan assistance is a way to differentiate in a tight labor market.

  • Business Wire3 days ago

    Aetna to Announce Third-Quarter 2018 Results

    Aetna today announced that third-quarter 2018 results will be made public on Tuesday, October 30, at 6:30 a.m. ET. Given the pending transaction with CVS Health, Aetna will not host a conference call in conjunction with its earnings release.

  • UNH Stock Up 4.1% on Solid Q3 2018 Results, View Up
    Market Realist3 days ago

    UNH Stock Up 4.1% on Solid Q3 2018 Results, View Up

    UNH Stock Up 4.1% on Solid Q3 2018 Results, View UpUnitedHealth Group reports its Q3 2018 earnings results

  • InvestorPlace7 days ago

    DOJ Approval Means Time to Take Profits on Aetna Stock

    In late October 2017, U.S. drugstore operator CVS Health Corp (NYSE:CVS) announced intentions to acquire U.S. health insurer Aetna Inc (NYSE:AET) in a $69 billion dollar deal that promised to permanently alter the healthcare industry. DOJ approval means that it is time to take profits on Aetna stock. Aetna stock initially jumped to nearly $200 by January 2018.

  • CVS Gets Department of Justice Approval for Aetna Deal
    Market Realist7 days ago

    CVS Gets Department of Justice Approval for Aetna Deal

    On October 10, the US Department of Justice gave preliminary approval to the $69 billion deal between CVS Health (CVS) and Aetna (AET). CVS Health, America’s largest pharmacy chain, proposed the acquisition of Aetna, the country’s third-largest insurance company, in December 2017 for $207 per share. The clearance from the DOJ is among the most important milestones towards completing the deal.

  • Why CVS Health Corporation Stock Is Falling Today
    Motley Fool8 days ago

    Why CVS Health Corporation Stock Is Falling Today

    A green light for its Aetna acquisition and disappointing revenue for a key rival weigh on the pharmacy services giant.

  • What the COO of an Albany area physician group thinks of the CVS, Aetna deal
    American City Business Journals8 days ago

    What the COO of an Albany area physician group thinks of the CVS, Aetna deal

    Joan Hayner is paying attention to the new models emerging in the health care industry as she looks at how Community Care Physicians delivers its services.

  • The Wall Street Journal9 days ago

    Justice Department Approves CVS-Aetna Deal

    Justice Department antitrust enforcers cleared CVS Health Corp.’s acquisition of Aetna Inc. after the companies took steps to ease regulators’ concerns, moving the nearly $70 billion deal a major step closer. The Wall Street Journal had earlier reported that federal antitrust officials were preparing to give the deal a green light, but the overlap in the two companies’ Medicare drug businesses had to be addressed. Aetna in late September announced the planned divestiture of its Medicare drug business to WellCare Health Plans Inc.

  • Reuters9 days ago

    CVS, Aetna win U.S. approval for $69 billion deal

    WASHINGTON/NEW YORK (Reuters) - Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers. The companies have said they will save administrative and patient care costs when they combine, in part by steering Aetna customers to walk-in clinics in CVS stores for less expensive medical services. It is the second large recent healthcare deal to win U.S. Justice Department approval.

  • Dow drops 831 points, S&P 500 posts five-day losing streak
    Yahoo Finance9 days ago

    Dow drops 831 points, S&P 500 posts five-day losing streak

    The Dow, S&P and Nasdaq booked their worst single-day selloffs in months.

  • UnitedHealth Group’s Q3 2018 Earnings Estimate
    Market Realist9 days ago

    UnitedHealth Group’s Q3 2018 Earnings Estimate

    When UnitedHealth Group (UNH) releases its third quarter of fiscal 2018 earnings results on October 16, analysts expect it to register adjusted EPS of ~$3.29, a ~23.8% growth YoY (year-over-year). In the second quarter, it reported adjusted EPS of ~$3.14, representing a ~27.6% YoY growth.

  • Can UnitedHealth Meet Analysts’ Revenue Estimate in Q3 2018?
    Market Realist9 days ago

    Can UnitedHealth Meet Analysts’ Revenue Estimate in Q3 2018?

    On October 16, UnitedHealth Group (UNH) is expected to announce its third quarter of fiscal 2018 earnings. Its sales are expected to grow 12% YoY (year-over-year) to $56.3 billion. In the second quarter of fiscal 2018, it had sales of $56.1 billion, representing ~12.1% YoY growth, which was in line with analysts’ estimates.

  • CVS-Aetna Merger Wins Approval Only to Face Debt Cliff
    Bloomberg9 days ago

    CVS-Aetna Merger Wins Approval Only to Face Debt Cliff

    Or at the very least, it has no problem when it comes to these types of deals and health care. CVS Health Corp.’s $69 billion purchase of insurer Aetna Inc. — the fifth-largest health-care deal ever — got conditional approval from the Department of Justice on Wednesday. The DOJ only requires the already in-progress divestiture of Aetna’s Medicare drug plans in order to approve the deal.

  • Business Wire9 days ago

    Aetna Offers Assistance Ahead of Hurricane Michael

    Aetna is offering resources to members who may be impacted by Hurricane Michael in Alabama, Florida and Georgia.

  • Analyst Ratings for UnitedHealth before Q3 2018 Earnings
    Market Realist9 days ago

    Analyst Ratings for UnitedHealth before Q3 2018 Earnings

    UnitedHealth Group (UNH) is the leading health insurance company in the United States. This managed healthcare company is focused on establishing itself as a diversified healthcare business and has been recently undertaking a number of strategic acquisitions aimed at that goal.

  • CVS, Aetna win U.S. approval for $69 billion deal
    Reuters9 days ago

    CVS, Aetna win U.S. approval for $69 billion deal

    WASHINGTON/NEW YORK (Reuters) - Pharmacy chain CVS Health Corp (CVS.N) won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc (AET.N), the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers. The companies have said they will save administrative and patient care costs when they combine, in part by steering Aetna customers to walk-in clinics in CVS stores for less expensive medical services. It is the second large recent healthcare deal to win U.S. Justice Department approval.

  • Benzinga9 days ago

    CVS Is One Step Closer To Buying Aetna

    CVS Health Corporation (NYSE: CVS ) is one step closer to acquiring Aetna Inc. (NYSE: AET ) after the U.S. Department of Justice preliminary approved the $69 billion merger. What Happened CVS proposed ...

  • TheStreet.com9 days ago

    CVS-Aetna Deal Gets Conditional Approval from DOJ

    have received conditional approval from the Department of Justice on their $69 billion merger. The DOJ said Wednesday, Oct. 10, it is requiring the companies to divest Aetna's Medicare Part D prescription drug business in order to go through with the transaction. The deal announced by Aetna on Sept. 27 to sell its Medicare Part D prescription drug plan business to WellCare Health Plans Inc. WCG will fully resolve the DOJ's concerns on competition, according to the news release.

  • DOJ approves $69B CVS Health-Aetna merger, with conditions
    Associated Press9 days ago

    DOJ approves $69B CVS Health-Aetna merger, with conditions

    The proposed $69 billion merger between CVS Health and Aetna is getting a greenlight from the Department of Justice, with some conditions. The Justice Department on Wednesday approved the deal on the condition that Aetna moves ahead with its plan to sell its Medicare Part D prescription drug plan business, resolving some anti-monopoly issues. Aetna announced last month it'd sell the business for an undisclosed amount.

  • PR Newswire9 days ago

    CVS Health Acquisition of Aetna Moving Forward on Agreement with U.S. Department of Justice

    WOONSOCKET, R.I., Oct. 10, 2018 /PRNewswire/ -- CVS Health (CVS) today announced that it has entered into an agreement with the U.S. Department of Justice (DOJ) that allows it to proceed with its proposed acquisition of Aetna (AET). DOJ clearance is a key milestone toward finalizing the transaction, which is also subject to state regulatory approvals, many of which have been granted. CVS Health's acquisition of Aetna remains on track to close in the early part of Q4 2018.